Stay updated with breaking news from Category All. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Liquid biopsy specialist Angle announced a supplier agreement with AstraZeneca on Wednesday to develop and validate a methodology using Angle's existing DNA damage response (DDR) assay for the detection of micronuclei in circulating tumour cells (CTCs) as a measure of DDR.
Investors' attention on Thursday will be on a first reading for U.S. gross domestic product growth during the first quarter.
London markets closed the day weaker on Wednesday, reversing earlier gains as Wall Street stocks opened lower, although mining stocks remained above the waterline.
Content creation hardware and software company Videndum reported a challenging 2023 on Tuesday, impacted by writer and actor strikes in the US and a difficult macroeconomic environment, and destocking.